Drug Use During Pregnancy, Birth and Early Development

National Clinical Guidelines for the Management of Drug Use During Pregnancy, Birth and the Early Development Years of the Newborn

These nationally agreed clinical guidelines are intended to support a range of health care workers who care for women with drug and alcohol use issues, and their infants and families.

They have been developed through a process based on evidence reviews and expert consensus.

The drugs covered include: opioids, alcohol, tobacco, cannabis, amphetamines, cocaine, benzodiazepines, inhalants.

Other topics covered are: breastfeeding, vertical transmission of blood-borne viruses, psychosocial aspects, obstetric implications, pain management in labour and early childhood development. Aboriginal and Torres Strait Islander issues are also addressed.